[Skip to content]

Cancer Advice - from leading UK Cancer Specialists
Find information
In this section...
On this site...
.

Weekly Cisplatinum adds to standard radiotherapy in the cure rates in Nasopharynx Carcinoma

A recent trial reported from Hong Kong (where the incidence of nasopharynx carcinoma is very high) has demonstrated that the addition of weekly cis-platinum chemotherapy, during the conventionally fractionated radiotherapy course increase the cure rate in this disease). This is another trial supporting the use of concurrent chemotherapy and radiotherapy in head and neck cancer.